Boerse Stuttgart Partners With DekaBank to Offer Crypto Trading for Institutional Clients
The collaboration comes as part of the exchange’s plan to expand partnerships with major financial institutions.
News
Integral Ad Science’s (NASDAQ:IAS) Q4 Sales Top Estimates, Stock Soars
Ad verification company Integral Ad Science (NASDAQ:IAS) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 14% year on year to $153 million. Guidance for next quarter’s revenue was better than expected at $129.5 million at the midpoint, 1.9% above analysts’ estimates. Its GAAP profit of $0.09 per share was 20% below analysts’ consensus estimates.
5 Things to Know Before the Stock Market Opens
News of the day for Feb. 28, 2025
Crypto Daybook Americas: Bitcoin Meltdown Worsens as Macro Jitters Overshadow Positives
Your day-ahead look for Feb. 28, 2025
Wall Street worried that new tariffs will turn the Trump bump into a slump—analysts warn the bulk of action is yet to come
Even unfilled tariff threats are beginning to alter consumer and business behavior, with markets stumbling on news of yet more sanctions on China.
Drug Stocks Are the New Safe Bet in a Shaky Market
After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced better-than-expected revenue in Q4 CY2024, with sales up 44.8% year on year to $190.6 million. The company’s full-year revenue guidance of $766 million at the midpoint came in 5.7% above analysts’ estimates. Its non-GAAP profit of $1.63 per share was 13.6% above analysts’ consensus estimates.